NCT02229786View on ClinicalTrials.gov

Efficacy and Tolerability of Buscopan Plus in Painful Gastric or Intestinal Spasms

PHASE2CompletedINTERVENTIONAL
Enrollment

1,637

Participants

Timeline

Start Date

February 28, 1998

Primary Completion Date

October 31, 1999

Conditions
Gastrointestinal Diseases
Interventions
DRUG

Buscopan® plus

DRUG

Buscopan®

DRUG

Paracetamol

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY